Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FB.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.8.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBZNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BR.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.79NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.587NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.232NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.60NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.333NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.437NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.452NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.400NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.16 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.46.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.37 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-16669.2Singapore
B.1.336NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.258NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.426NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.399NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.337NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.539NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.164NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.392NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.319NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used